University of Minnesota-MNCCTN037: Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Objective

This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging symptoms to manage in patients with cancer, both on or off active treatment. This symptom complex meaningfully contributes to psychosocial distress, healthcare costs, and it also interferes with the delivery of anticancer therapies. American ginseng (Western ginseng) appears to be a promising appearing agent for treating cancer related fatigue. Western ginseng may reduce cancer-related fatigue.

National Clinical Trial (NCT) Number: 06395441

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT06395441

Location: Essentia Health Cancer Centers

Research Study Categories

Specialties

  • Cancer

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]

X

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. See website policy